ctx130
crispr therapeutics ag
['ctx130', 'cobalt,rcc', 'crispr']
 presents revealing results from the cobalt-rcc trial w/ ctx130, a crispr-edited cd70 allocar. 1 cr (18mo &amp; ongoing) &amp; 9/13 sd (upwards of 7.8mo off any tx). 7/13 g1-2 crs. durable crs w/ allocars are possible, and highlight their potential. #sitc22 